Roy Ovel

Chief Commercial Officer

Roy Ovel is the Chief Commercial Officer for Ergomed Group with a wealth of experience working for more than 30 years in international business development with some of the leading global CROs.

Roy has experience of working globally with virtual as well as large pharma across the drug development continuum. His reputation as a leader with strong commercial acumen focused on working with customers to really meet their needs is key in an environment where demands on pharmaceutical and biotech customers continues to grow. Before joining Ergomed plc, Roy has worked for both small local CROs as well as the larger CROs like ICON, TFS and Worldwide Clinical Trials and his experience in meeting clients challenges and ensuring the growth of companies is aligned with the customers needs has been the key to Roy’s success. He is highly customer focused with an ability to develop high performing teams whilst maintaining an holistic approach to business.

This site uses cookies to personalise and customise your experience. By clicking “I Accept", you consent to cookies in accordance with our privacy policy.

Privacy Settings saved!
Cookie Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

  • __cfduid

Decline all Services
Accept all Services